1. c-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells
   Erica Leonetti et al, 2019, International Journal of Molecular Sciences CrossRef
2. CircTMTC1 contributes to nasopharyngeal carcinoma progression through targeting miR-495-MET-eIF4G1 translational regulation axis
   Yajie Zhao et al, 2022, Cell Death & Disease CrossRef
3. RTKs in pathobiology of head and neck cancers
   Revathy Nadhan et al, 2020, Receptor Tyrosine Kinases CrossRef
4. Anticancer molecular mechanisms of oleocanthal
   Mohammed El Haouari et al, 2020, Phytotherapy Research CrossRef
5. S-(−)-Oleocanthal as a c-Met receptor tyrosine kinase inhibitor and its application to synergize targeted therapies and prevent breast cancer recurrence
   Khalid A. El Sayed, 2021, Olives and Olive Oil in Health and Disease Prevention CrossRef
6. Molecular simulation studies on the binding activity and selectivity of 3-amino-phenyl-5-chloro-pyrimidine-2, 4-diamine derivatives in complexes with kinases c-Met and ALK
   You-Lu Pan et al, 2019, Molecular Simulation CrossRef
7. Cancer stem cells as therapeutic targets of pancreatic cancer
   Ebrahim Razi et al, 2020, Fundamental & Clinical Pharmacology CrossRef
8. Aberrant intracellular metabolism of T‐DM1 confers T‐DM1 resistance in human epidermal growth factor receptor 2‐positive gastric cancer cells
   Hongbin Wang et al, 2017, Cancer Science CrossRef
9. STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening
   Chun-Chia Cheng et al, 2018, Journal of Biomedical Science CrossRef
10. c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
    Katia Corano Scheri et al, 2018, Oncotarget CrossRef
11. Epidermal growth factor induces STAT1 expression to exacerbate the IFNr‐mediated PD‐L1 axis in epidermal growth factor receptor‐positive cancers
    Chun‐Chia Cheng et al, 2018, Molecular Carcinogenesis CrossRef
12. (−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo
    Abu Siddique et al, 2019, Nutrients CrossRef
13. (−)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer
    Abu Bakar Siddique et al, 2020, Nutrients CrossRef
14. Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy
    Wenjie Wang et al, 2019, Current Topics in Medicinal Chemistry CrossRef
15. C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas
    Paulina Marona et al, 2019, Cells CrossRef
16. SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer
    Katia De Marco et al, 2023, Cells CrossRef
17. Mesenchymal Epithelial Transition (MET): A Key Player in Chemotherapy Resistance and an Emerging Target for Potentiating Cancer Immunotherapy
    Kenneth K.W. To et al, 2022, Current Cancer Drug Targets CrossRef